CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Biotech
Original article

Boston Scientific announces results for second quarter 2026

EarningsPositive
AI Analysis

Summary

Boston Scientific reported Q2 2026 net sales of $5.442 billion, representing 7.5% reported growth and 7.0% operational and organic growth compared to the prior year.

Financial Highlights

Revenue

$5.442 billion

Importance:3/10
Sentiment:
0.30
earningsQ2_2026revenue_growth
Related Companies

Read the original article

Published by PR Newswire Biotech on July 29, 2026 10:30 AM

Read Original